Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
about
α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson diseaseGenetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophyGenetic susceptibility in Parkinson's diseaseGenetic regulation of alpha-synuclein mRNA expression in various human brain tissues.Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo.Lewy bodies.Gene-environment interactions in sporadic Parkinson's disease.Key issues in essential tremor genetics research: Where are we now and how can we move forward?Up-regulation of SNCA gene expression: implications to synucleinopathiesExpansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain.Aggregates assembled from overexpression of wild-type alpha-synuclein are not toxic to human neuronal cellsGenetic variability in SNCA and Parkinson's disease.α-Synuclein and mitochondrial dysfunction in Parkinson's disease.Models of α-synuclein aggregation in Parkinson's disease.Structural variants in SNCA gene and the implication to synucleinopathies.Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.Progression of pathology in PINK1-deficient mouse brain from splicing via ubiquitination, ER stress, and mitophagy changes to neuroinflammation.Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease.
P2860
Q21090919-E3A37430-5255-4C23-B061-A8BDDA0391E4Q21142744-E01B41AC-BFE2-459E-AF25-F91E35F385FEQ30435626-A2BF77ED-87CA-49F8-B7CF-141C6978D5CBQ33510936-D5C87BB0-3DAE-440A-8174-7C93D5D0B835Q33885205-AD62B998-06E4-4434-ABC9-A0C682EA6EA7Q34478663-E19F7DFE-9683-4CFE-BCCA-46DDD9127B44Q36521952-3036A0D7-ADC3-49AD-AE31-E2614104AEB9Q36640329-AEF8E340-D2AC-461E-9D13-8466EFA71BB6Q37004246-BC6E94F3-9602-4B29-BFE0-8B745AF872B5Q37295073-AB9B98C6-39F7-480F-AF22-3F046FB3D46EQ37401007-D4384C21-6FE0-442A-8621-6CE5BABD75DBQ37907930-C53ADBC3-D47F-4D27-AA3F-FECEF53FC533Q38077665-5495075B-6407-4363-97F2-AD28FFFA1A7CQ38286574-6B6CE337-3E74-4FBA-BA51-88E396304EB5Q39188180-C8193131-5CCA-4884-A7E1-C2430672C569Q39264615-CE1D7099-3A52-4774-ADE9-A434B36E1EA9Q41228349-D92A77CC-B515-40EA-8D4D-824078AA7BD9Q41954719-BC997D9A-08ED-49FC-9B4F-5D01E174FB30Q52568381-D0F5746F-910C-4C31-BA09-ECBABA65255B
P2860
Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Australian data and meta-analy ...... actor for Parkinson's disease.
@ast
Australian data and meta-analy ...... actor for Parkinson's disease.
@en
type
label
Australian data and meta-analy ...... actor for Parkinson's disease.
@ast
Australian data and meta-analy ...... actor for Parkinson's disease.
@en
prefLabel
Australian data and meta-analy ...... actor for Parkinson's disease.
@ast
Australian data and meta-analy ...... actor for Parkinson's disease.
@en
P921
P1433
P1476
Australian data and meta-analy ...... actor for Parkinson's disease.
@en
P2093
Demetrius M Maraganore
P304
P356
10.1016/J.NEULET.2004.10.078
P407
P577
2004-11-23T00:00:00Z